Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diethylamine SCHEMBL11565851 | 1.00 | TP53 (0.73) | — | |
| Diethylamine SCHEMBL509438 | 0.95 | — | — | |
| Diethylamine SCHEMBL27879298 | 0.91 | — | — | |
| Diethylamine SCHEMBL11583123 | 0.91 | TP53 (0.73) | — | |
| Diethylamine SCHEMBL31276499 | 0.91 | TP53 (0.89) | — | |
| Diethylamine SCHEMBL27888306 | 0.91 | TP53 (0.89) | — | |
| Diethylamine SCHEMBL104362 | 0.91 | — | — | |
| Diethylamine SCHEMBL9329994 | 0.89 | TP53 (0.57) | — | |
| Diethylamine SCHEMBL11564718 | 0.87 | TP53 (0.67) | — | |
| Diethylamine SCHEMBL2240691 | 0.87 | TP53 (0.67) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118032957-A | Method for detecting eperisone hydrochloride related substances | 康普药业股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117720481-A | Preparation method of eperisone hydrochloride and application of eperisone hydrochloride in preparation | 重庆圣华曦药业股份有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117298056-A | Stable eperisone hydrochloride tablet and preparation method thereof | 康普药业股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| EP-1620437-B1 | 5,7-DIAMINOPYRAZOLO¬4,3-D PYRIMIDINES USEFUL IN THE TRAETMENT OF HYPERTENSION | PFIZER LTD (GB) | 2009-06-17 | — | — | EP | disclosed |
| US-20070270412-A1 | NOVEL PHARMACEUTICALS | PFIZER INC | 2007-11-22 | — | — | US | disclosed |
| US-7262192-B2 | Substituted pyrazolo[4,3-d]pyrimidines and their use as PDE-5 inhibitors | PFIZER INC. (US) | 2007-08-28 | — | — | US | disclosed |
| EP-1620437-A1 | 5,7-DIAMINOPYRAZOLO[4,3-D]PYRIMIDINES USEFUL IN THE TRAETMENT OF HYPERTENSION | Pfizer Limited (GB) | 2006-02-01 | — | — | EP | disclosed |
| US-20050043325-A1 | Novel pharmaceuticals | PFIZER INC | 2005-02-24 | — | — | US | disclosed |
| WO-2004096810-A1 | 5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION | PFIZER LIMITED (GB) | 2004-11-11 | — | — | WO | disclosed |
| US-6458951-B2 | FOR TREATMENT OF MALE ERECTILE DYSFUNCTION, FEMALE SEXUAL DYSFUNCTION | PFIZER INC | 2002-10-01 | — | — | US | disclosed |